 | • レポートコード：MR2211M-4455 • 出版社/出版日：Market Monitor Global / 2022年5月 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2-3日） • 産業分類：医療装置 |
| Single User | ￥481,000 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥721,500 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料は次の情報を含め、PoC感染症検査のグローバル市場規模と予測を記載しています。・PoC感染症検査のグローバル市場：売上、2017年-2022年、2023年-2028年 ・PoC感染症検査のグローバル市場：販売量、2017年-2022年、2023年-2028年 ・世界のトップ5企業、2021年 PoC感染症検査のグローバル市場規模は2021年に000Mドルと評価され、予測期間中に000％のCAGRで2028年までに000Mドルに達すると予測されています。米国市場は2021年に000Mドルと推定されており、中国は2028年までに000Mドルに達すると予測されています。「HIV POC」セグメントは今後6年間、000%のCAGRで2028年までに000Mドルに成長すると予測されています。 PoC感染症検査のグローバル主要企業は、Alere、 Thermo Fisher Scientific、 F. Hoffmann-La Roche、 Siemens Healthineers、 BD、 Chembio Diagnostics、 Trinity Biotech、 Cardinal Health、 Quest Diagnostics、 Bio-Rad Labs、 bioMérieux、 Sight Diagnostics、 Gene POC、 Trivitron Healthcare、 OJ-Bio、 Ortho-Clinical Diagnosticsなどです。2021年にトップ5企業がグローバル売上シェアの約000%を占めています。 マーケットモニターグローバル（MMG）社は、PoC感染症検査のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のPoC感染症検査市場：タイプ別、2017年-2022年、2023年-2028年 世界のPoC感染症検査市場：タイプ別市場シェア、2021年 ・HIV POC、HBV POC、肺炎/連鎖球菌関連感染症、呼吸器合胞体ウイルス（RSV）POC、HPV POC、インフルエンザPOC、その他 世界のPoC感染症検査市場：用途別、2017年-2022年、2023年-2028年 世界のPoC感染症検査市場：用途別市場シェア、2021年 ・病院、クリニック、家庭用、その他 世界のPoC感染症検査市場：地域・国別、2017年-2022年、2023年-2028年 世界のPoC感染症検査市場：地域別市場シェア、2021年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるPoC感染症検査のグローバル売上、2017年-2022年 ・主要企業におけるPoC感染症検査のグローバル売上シェア、2021年 ・主要企業におけるPoC感染症検査のグローバル販売量、2017年-2022年 ・主要企業におけるPoC感染症検査のグローバル販売量シェア、2021年 さらに、当レポートは主要企業のプロファイルを提示します。 Alere、 Thermo Fisher Scientific、 F. Hoffmann-La Roche、 Siemens Healthineers、 BD、 Chembio Diagnostics、 Trinity Biotech、 Cardinal Health、 Quest Diagnostics、 Bio-Rad Labs、 bioMérieux、 Sight Diagnostics、 Gene POC、 Trivitron Healthcare、 OJ-Bio、 Ortho-Clinical Diagnostics ************************************************************* ・調査・分析レポートの概要 PoC感染症検査市場の定義 市場セグメント 世界のPoC感染症検査市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のPoC感染症検査市場規模 世界のPoC感染症検査市場規模：2021年 VS 2028年 世界のPoC感染症検査市場規模と予測 2017年-2028年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのPoC感染症検査の売上 グローバルトップ3およびトップ5企業、2021年売上ベース グローバル企業のPoC感染症検査製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：HIV POC、HBV POC、肺炎/連鎖球菌関連感染症、呼吸器合胞体ウイルス（RSV）POC、HPV POC、インフルエンザPOC、その他 PoC感染症検査のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、クリニック、家庭用、その他 PoC感染症検査の用途別グローバル売上・予測 ・地域別市場分析 地域別PoC感染症検査市場規模 2021年と2028年 地域別PoC感染症検査売上・予測 北米市場 - アメリカのPoC感染症検査市場規模2017年-2028年 - カナダのPoC感染症検査市場規模2017年-2028年 - メキシコのPoC感染症検査市場規模2017年-2028年 ヨーロッパ市場 - ドイツのPoC感染症検査市場規模2017年-2028年 - フランスのPoC感染症検査市場規模2017年-2028年 - イギリスのPoC感染症検査市場規模2017年-2028年 - イタリアのPoC感染症検査市場規模2017年-2028年 - ロシアのPoC感染症検査市場規模2017年-2028年 アジア市場 - 中国のPoC感染症検査市場規模2017年-2028年 - 日本のPoC感染症検査市場規模2017年-2028年 - 韓国のPoC感染症検査市場規模2017年-2028年 - 東南アジアのPoC感染症検査市場規模2017年-2028年 - インドのPoC感染症検査市場規模2017年-2028年 南米市場 - ブラジルのPoC感染症検査市場規模2017年-2028年 - アルゼンチンのPoC感染症検査市場規模2017年-2028年 中東・アフリカ市場 - トルコのPoC感染症検査市場規模2017年-2028年 - イスラエルのPoC感染症検査市場規模2017年-2028年 - サウジアラビアのPoC感染症検査市場規模2017年-2028年 - UAEのPoC感染症検査市場規模2017年-2028年 ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Alere、 Thermo Fisher Scientific、 F. Hoffmann-La Roche、 Siemens Healthineers、 BD、 Chembio Diagnostics、 Trinity Biotech、 Cardinal Health、 Quest Diagnostics、 Bio-Rad Labs、 bioMérieux、 Sight Diagnostics、 Gene POC、 Trivitron Healthcare、 OJ-Bio、 Ortho-Clinical Diagnostics ... |
Infectious disease doctors test your blood or other body fluids to look for specific antibodies — cells produced by our immune system to fight harmful foreign substances. These tests can indicate what kind of infection is present. For bacterial infections, treatment usually involves antibiotics. Launch of mobile & self-testing devices has increased access to testing and monitoring systems to the remote places where the provision of timely medical care is a challenge.
This report contains market size and forecasts of Point of Care Infectious Disease Testing in Global, including the following market information:
Global Point of Care Infectious Disease Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Point of Care Infectious Disease Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
HIV POC Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Point of Care Infectious Disease Testing include Alere, Thermo Fisher Scientific, F. Hoffmann-La Roche, Siemens Healthineers, BD, Chembio Diagnostics, Trinity Biotech, Cardinal Health and Quest Diagnostics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Point of Care Infectious Disease Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Point of Care Infectious Disease Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Point of Care Infectious Disease Testing Market Segment Percentages, by Type, 2021 (%)
HIV POC
HBV POC
Pneumonia or Streptococcus Associated Infections
Respiratory Syncytial Virus (RSV) POC
HPV POC
Influenza POC
Others
Global Point of Care Infectious Disease Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Point of Care Infectious Disease Testing Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Home
Others
Global Point of Care Infectious Disease Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Point of Care Infectious Disease Testing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Point of Care Infectious Disease Testing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Point of Care Infectious Disease Testing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alere
Thermo Fisher Scientific
F. Hoffmann-La Roche
Siemens Healthineers
BD
Chembio Diagnostics
Trinity Biotech
Cardinal Health
Quest Diagnostics
Bio-Rad Labs
bioMérieux
Sight Diagnostics
Gene POC
Trivitron Healthcare
OJ-Bio
Ortho-Clinical Diagnostics
1 Introduction to Research & Analysis Reports
1.1 Point of Care Infectious Disease Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Point of Care Infectious Disease Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Point of Care Infectious Disease Testing Overall Market Size
2.1 Global Point of Care Infectious Disease Testing Market Size: 2021 VS 2028
2.2 Global Point of Care Infectious Disease Testing Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Point of Care Infectious Disease Testing Players in Global Market
3.2 Top Global Point of Care Infectious Disease Testing Companies Ranked by Revenue
3.3 Global Point of Care Infectious Disease Testing Revenue by Companies
3.4 Top 3 and Top 5 Point of Care Infectious Disease Testing Companies in Global Market, by Revenue in 2021
3.5 Global Companies Point of Care Infectious Disease Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Point of Care Infectious Disease Testing Players in Global Market
3.6.1 List of Global Tier 1 Point of Care Infectious Disease Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Point of Care Infectious Disease Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type – Global Point of Care Infectious Disease Testing Market Size Markets, 2021 & 2028
4.1.2 HIV POC
4.1.3 HBV POC
4.1.4 Pneumonia or Streptococcus Associated Infections
4.1.5 Respiratory Syncytial Virus (RSV) POC
4.1.6 HPV POC
4.1.7 Influenza POC
4.1.8 Others
4.2 By Type – Global Point of Care Infectious Disease Testing Revenue & Forecasts
4.2.1 By Type – Global Point of Care Infectious Disease Testing Revenue, 2017-2022
4.2.2 By Type – Global Point of Care Infectious Disease Testing Revenue, 2023-2028
4.2.3 By Type – Global Point of Care Infectious Disease Testing Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Point of Care Infectious Disease Testing Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Home
5.1.5 Others
5.2 By Application – Global Point of Care Infectious Disease Testing Revenue & Forecasts
5.2.1 By Application – Global Point of Care Infectious Disease Testing Revenue, 2017-2022
5.2.2 By Application – Global Point of Care Infectious Disease Testing Revenue, 2023-2028
5.2.3 By Application – Global Point of Care Infectious Disease Testing Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region – Global Point of Care Infectious Disease Testing Market Size, 2021 & 2028
6.2 By Region – Global Point of Care Infectious Disease Testing Revenue & Forecasts
6.2.1 By Region – Global Point of Care Infectious Disease Testing Revenue, 2017-2022
6.2.2 By Region – Global Point of Care Infectious Disease Testing Revenue, 2023-2028
6.2.3 By Region – Global Point of Care Infectious Disease Testing Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country – North America Point of Care Infectious Disease Testing Revenue, 2017-2028
6.3.2 US Point of Care Infectious Disease Testing Market Size, 2017-2028
6.3.3 Canada Point of Care Infectious Disease Testing Market Size, 2017-2028
6.3.4 Mexico Point of Care Infectious Disease Testing Market Size, 2017-2028
6.4 Europe
6.4.1 By Country – Europe Point of Care Infectious Disease Testing Revenue, 2017-2028
6.4.2 Germany Point of Care Infectious Disease Testing Market Size, 2017-2028
6.4.3 France Point of Care Infectious Disease Testing Market Size, 2017-2028
6.4.4 U.K. Point of Care Infectious Disease Testing Market Size, 2017-2028
6.4.5 Italy Point of Care Infectious Disease Testing Market Size, 2017-2028
6.4.6 Russia Point of Care Infectious Disease Testing Market Size, 2017-2028
6.4.7 Nordic Countries Point of Care Infectious Disease Testing Market Size, 2017-2028
6.4.8 Benelux Point of Care Infectious Disease Testing Market Size, 2017-2028
6.5 Asia
6.5.1 By Region – Asia Point of Care Infectious Disease Testing Revenue, 2017-2028
6.5.2 China Point of Care Infectious Disease Testing Market Size, 2017-2028
6.5.3 Japan Point of Care Infectious Disease Testing Market Size, 2017-2028
6.5.4 South Korea Point of Care Infectious Disease Testing Market Size, 2017-2028
6.5.5 Southeast Asia Point of Care Infectious Disease Testing Market Size, 2017-2028
6.5.6 India Point of Care Infectious Disease Testing Market Size, 2017-2028
6.6 South America
6.6.1 By Country – South America Point of Care Infectious Disease Testing Revenue, 2017-2028
6.6.2 Brazil Point of Care Infectious Disease Testing Market Size, 2017-2028
6.6.3 Argentina Point of Care Infectious Disease Testing Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Point of Care Infectious Disease Testing Revenue, 2017-2028
6.7.2 Turkey Point of Care Infectious Disease Testing Market Size, 2017-2028
6.7.3 Israel Point of Care Infectious Disease Testing Market Size, 2017-2028
6.7.4 Saudi Arabia Point of Care Infectious Disease Testing Market Size, 2017-2028
6.7.5 UAE Point of Care Infectious Disease Testing Market Size, 2017-2028
7 Players Profiles
7.1 Alere
7.1.1 Alere Corporate Summary
7.1.2 Alere Business Overview
7.1.3 Alere Point of Care Infectious Disease Testing Major Product Offerings
7.1.4 Alere Point of Care Infectious Disease Testing Revenue in Global Market (2017-2022)
7.1.5 Alere Key News
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Corporate Summary
7.2.2 Thermo Fisher Scientific Business Overview
7.2.3 Thermo Fisher Scientific Point of Care Infectious Disease Testing Major Product Offerings
7.2.4 Thermo Fisher Scientific Point of Care Infectious Disease Testing Revenue in Global Market (2017-2022)
7.2.5 Thermo Fisher Scientific Key News
7.3 F. Hoffmann-La Roche
7.3.1 F. Hoffmann-La Roche Corporate Summary
7.3.2 F. Hoffmann-La Roche Business Overview
7.3.3 F. Hoffmann-La Roche Point of Care Infectious Disease Testing Major Product Offerings
7.3.4 F. Hoffmann-La Roche Point of Care Infectious Disease Testing Revenue in Global Market (2017-2022)
7.3.5 F. Hoffmann-La Roche Key News
7.4 Siemens Healthineers
7.4.1 Siemens Healthineers Corporate Summary
7.4.2 Siemens Healthineers Business Overview
7.4.3 Siemens Healthineers Point of Care Infectious Disease Testing Major Product Offerings
7.4.4 Siemens Healthineers Point of Care Infectious Disease Testing Revenue in Global Market (2017-2022)
7.4.5 Siemens Healthineers Key News
7.5 BD
7.5.1 BD Corporate Summary
7.5.2 BD Business Overview
7.5.3 BD Point of Care Infectious Disease Testing Major Product Offerings
7.5.4 BD Point of Care Infectious Disease Testing Revenue in Global Market (2017-2022)
7.5.5 BD Key News
7.6 Chembio Diagnostics
7.6.1 Chembio Diagnostics Corporate Summary
7.6.2 Chembio Diagnostics Business Overview
7.6.3 Chembio Diagnostics Point of Care Infectious Disease Testing Major Product Offerings
7.6.4 Chembio Diagnostics Point of Care Infectious Disease Testing Revenue in Global Market (2017-2022)
7.6.5 Chembio Diagnostics Key News
7.7 Trinity Biotech
7.7.1 Trinity Biotech Corporate Summary
7.7.2 Trinity Biotech Business Overview
7.7.3 Trinity Biotech Point of Care Infectious Disease Testing Major Product Offerings
7.7.4 Trinity Biotech Point of Care Infectious Disease Testing Revenue in Global Market (2017-2022)
7.7.5 Trinity Biotech Key News
7.8 Cardinal Health
7.8.1 Cardinal Health Corporate Summary
7.8.2 Cardinal Health Business Overview
7.8.3 Cardinal Health Point of Care Infectious Disease Testing Major Product Offerings
7.8.4 Cardinal Health Point of Care Infectious Disease Testing Revenue in Global Market (2017-2022)
7.8.5 Cardinal Health Key News
7.9 Quest Diagnostics
7.9.1 Quest Diagnostics Corporate Summary
7.9.2 Quest Diagnostics Business Overview
7.9.3 Quest Diagnostics Point of Care Infectious Disease Testing Major Product Offerings
7.9.4 Quest Diagnostics Point of Care Infectious Disease Testing Revenue in Global Market (2017-2022)
7.9.5 Quest Diagnostics Key News
7.10 Bio-Rad Labs
7.10.1 Bio-Rad Labs Corporate Summary
7.10.2 Bio-Rad Labs Business Overview
7.10.3 Bio-Rad Labs Point of Care Infectious Disease Testing Major Product Offerings
7.10.4 Bio-Rad Labs Point of Care Infectious Disease Testing Revenue in Global Market (2017-2022)
7.10.5 Bio-Rad Labs Key News
7.11 bioMérieux
7.11.1 bioMérieux Corporate Summary
7.11.2 bioMérieux Business Overview
7.11.3 bioMérieux Point of Care Infectious Disease Testing Major Product Offerings
7.11.4 bioMérieux Point of Care Infectious Disease Testing Revenue in Global Market (2017-2022)
7.11.5 bioMérieux Key News
7.12 Sight Diagnostics
7.12.1 Sight Diagnostics Corporate Summary
7.12.2 Sight Diagnostics Business Overview
7.12.3 Sight Diagnostics Point of Care Infectious Disease Testing Major Product Offerings
7.12.4 Sight Diagnostics Point of Care Infectious Disease Testing Revenue in Global Market (2017-2022)
7.12.5 Sight Diagnostics Key News
7.13 Gene POC
7.13.1 Gene POC Corporate Summary
7.13.2 Gene POC Business Overview
7.13.3 Gene POC Point of Care Infectious Disease Testing Major Product Offerings
7.13.4 Gene POC Point of Care Infectious Disease Testing Revenue in Global Market (2017-2022)
7.13.5 Gene POC Key News
7.14 Trivitron Healthcare
7.14.1 Trivitron Healthcare Corporate Summary
7.14.2 Trivitron Healthcare Business Overview
7.14.3 Trivitron Healthcare Point of Care Infectious Disease Testing Major Product Offerings
7.14.4 Trivitron Healthcare Point of Care Infectious Disease Testing Revenue in Global Market (2017-2022)
7.14.5 Trivitron Healthcare Key News
7.15 OJ-Bio
7.15.1 OJ-Bio Corporate Summary
7.15.2 OJ-Bio Business Overview
7.15.3 OJ-Bio Point of Care Infectious Disease Testing Major Product Offerings
7.15.4 OJ-Bio Point of Care Infectious Disease Testing Revenue in Global Market (2017-2022)
7.15.5 OJ-Bio Key News
7.16 Ortho-Clinical Diagnostics
7.16.1 Ortho-Clinical Diagnostics Corporate Summary
7.16.2 Ortho-Clinical Diagnostics Business Overview
7.16.3 Ortho-Clinical Diagnostics Point of Care Infectious Disease Testing Major Product Offerings
7.16.4 Ortho-Clinical Diagnostics Point of Care Infectious Disease Testing Revenue in Global Market (2017-2022)
7.16.5 Ortho-Clinical Diagnostics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer